Next steps in prescription stimulants as a treatment for methamphetamine use disorder: Clinical implications of the LiMA trial

A discussion on the findings of the trial an expert panel discussion with clinicians, researchers and representatives with lived/living experience, and a live Q&A.
 

Summary  

Topics in the webinar included:

• An overview of the findings of a randomised, placebo-controlled trial of lisdexamfetamine in the treatment of methamphetamine use disorder (the LiMA trial)
• Clinical implications of the trial’s findings
• What this study could mean for clients and the treatment of methamphetamine use disorder

Speakers and Panelists

• Prof Nadine Ezard - presenter
• Prof Nicholas Lintzeris
• Dr Elizabeth Knock
• Adrian Tait
• Dr Lucy Watson - chair